The Global Automated Cell Culture Systems Industry is on the brink of a remarkable trajectory, poised for unprecedented growth with an impressive Compound Annual Growth Rate (CAGR) of 8.4%, as revealed by the latest projections from Future Market Insights Inc. This anticipated surge is expected to elevate the market from its 2022 valuation of US$ 10.91 Billion to an extraordinary US$ 20.87 Billion by the year 2030.
At the heart of this exceptional expansion is the burgeoning demand for advanced technologies in cell culture, fueled by rapid advancements in the realms of biotechnology and pharmaceuticals. The Global Automated Cell Culture Systems Industry stands as a beacon of innovation, introducing cutting-edge solutions that are revolutionizing global research and production processes.
The strategic geographical positioning of North America and Europe further solidifies their dominance in the Global Automated Cell Culture Systems Industry. The groundbreaking research initiatives and technological advancements undertaken by researchers in these regions continue to set the pace for global innovation.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-7860
Key Takeaways from the Global Automated Cell Culture Systems Industry
- Consumables are expected to reach US$ 11 Bn by 2030
- Academic institutes are expected to take greater interest in research related to cell culture over the forecast period due to increased government funding in developed countries
- North America and Europe collectively accounted for more than 60% of market share in 2019
- Infinite cell line cultures held close to 75% of market share in 2019
New Product Launches to Remain Key Strategic Focus of Market Players
Players in the Global Automated Cell Culture Systems Industry are focusing on new product launches to expand their global footprint and strengthen their product portfolio.
For instance –
- In Jun 2020, faCellitate announced the launch of “BIOFLOAT”, it’s very first product to improve 3D cell culture.
- In Mar 2020, BioProcess International started implementing single-use miniature bioreactors for supporting intensified cell culture by using functional performance indicators for assessing small-scale model
- Corning Incorporated, in Oct 2019, came up with Corning Elplasia Plates and Matrigel for organoid culture. It was an addition to its 3D cell culture portfolio
- Ori Biotech has started developing an automated way of manufacturing cell and gene therapies
- In May 2020, Sartorius announced the launch of the Incucyte SX5® for live-cell analysis, for live-cell analysis experiments
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7860
Global Automated Cell Culture Systems Industry: Competitive Insights
The Global Automated Cell Culture Systems Industry is set to expand its scope in the forecast period, stimulated by increasing drug discovery research and diverse applications of cell lines for research purposes. Furthermore, automated cell culture systems are used for experiments in drug discovery research and in the cell banking process. In addition, cost-effectiveness and the rise in alternative methods for traditional cell culture production are augmenting the adoption of automated cell culture systems.
Key market players covered in the market include:
Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Tecan Trading AG, Hamilton Medical AG., Biospherix, and Promocell GmbH. Key players integrate their positions through acquisitions, mergers, and new product launches.
Key Segments of Automated Cell Culture Systems Industry Survey
Global Automated Cell Culture Systems Industry by Product:
- Automated Cell Culture Storage Equipment
- Automated Cell Culture Vessels
- Bioreactors
- Consumables
Global Automated Cell Culture Systems Industry by Cell Culture:
- Finite Cell Line Cultures
- Infinite Cell Line Cultures
Global Automated Cell Culture Systems Industry by Application:
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
Global Automated Cell Culture Systems Industry by End User:
- Biotech Companies
- Research Organizations
- Academic Institutes
Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-7860
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube